Loading clinical trials...
Loading clinical trials...
Efficacy (Systemic and Cerebral) and Safety of PEMbrolizumab PD-L1-positive (More Than 50% of Tumor Cells), Advanced Non-small-cell Lung Cancer : A Study of Real Life in Brittany .
Conditions
Locations
2
France
CHRU de Brest
Brest, France
CHIC de QUIMPER
Quimper, France
Start Date
January 2, 2019
Primary Completion Date
January 2, 2019
Completion Date
March 2, 2019
Last Updated
April 11, 2022
NCT06667908
NCT04165798
NCT06875310
NCT07046923
NCT05689463
NCT07222566
Lead Sponsor
University Hospital, Brest
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions